These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33313161)

  • 1. Multi-omics analysis reveals the genetics and immune landscape of dexamethasone responsive genes in cancer microenvironment.
    Shen Y; Wu YC; Gu L
    Ann Transl Med; 2020 Nov; 8(21):1416. PubMed ID: 33313161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive pan-cancer analysis identifies cellular senescence as a new therapeutic target for cancer: multi-omics analysis and single-cell sequencing validation.
    Zhang Q; Tang Y; Hu G; Yuan Z; Zhang S; Sun Y; Yin D; Dong C; Zhao J; Wu G; Huang X; Yang J; Tang Y
    Am J Cancer Res; 2022; 12(9):4103-4119. PubMed ID: 36225642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Landscape of Ovarian Cancer Immune Microenvironment Based on Integrated Multi-Omics Analysis.
    Shen J; Liu T; Bei Q; Xu S
    Front Oncol; 2021; 11():685065. PubMed ID: 34222009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer.
    Xiao Y; Ma D; Zhao S; Suo C; Shi J; Xue MZ; Ruan M; Wang H; Zhao J; Li Q; Wang P; Shi L; Yang WT; Huang W; Hu X; Yu KD; Huang S; Bertucci F; Jiang YZ; Shao ZM;
    Clin Cancer Res; 2019 Aug; 25(16):5002-5014. PubMed ID: 30837276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data.
    Hao Y; Li D; Xu Y; Ouyang J; Wang Y; Zhang Y; Li B; Xie L; Qin G
    BMC Bioinformatics; 2019 May; 20(Suppl 7):195. PubMed ID: 31074374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-Omics Analysis Reveals the Pan-Cancer Landscape of Bone Morphogenetic Proteins.
    Luo WL; Luo MX; He RZ; Ying LF; Luo J
    Med Sci Monit; 2020 Apr; 26():e920943. PubMed ID: 32248202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative Analysis Reveals the Landscape of Hypoxia-Inducible Factor (HIF) Family Genes in Pan-Cancer.
    Yang QK; Wang XX; Wang Y; Ni N
    J Oncol; 2020; 2020():8873104. PubMed ID: 33299416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High copy number variations, particular transcription factors, and low immunity contribute to the stemness of prostate cancer cells.
    Dai Z; Liu P
    J Transl Med; 2021 May; 19(1):206. PubMed ID: 33985534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models.
    Koch MS; Zdioruk M; Nowicki MO; Griffith AM; Aguilar E; Aguilar LK; Guzik BW; Barone F; Tak PP; Tabatabai G; Lederer JA; Chiocca EA; Lawler S
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35017150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma.
    Huang Z; Li B; Guo Y; Wu L; Kou F; Yang L
    Front Immunol; 2021; 12():723172. PubMed ID: 34539658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comprehensive Multiomics Analysis Identified Ubiquilin 4 as a Promising Prognostic Biomarker of Immune-Related Therapy in Pan-Cancer.
    Li J; Tong Y; Wang Z; Liu Y; Dai X; Zhu Y
    J Oncol; 2021; 2021():7404927. PubMed ID: 34539785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Typical tumor immune microenvironment status determine prognosis in lung adenocarcinoma.
    Ren C; Li J; Zhou Y; Zhang S; Wang Q
    Transl Oncol; 2022 Apr; 18():101367. PubMed ID: 35176624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian clock associates with tumor microenvironment in thoracic cancers.
    Yang Y; Yuan G; Xie H; Wei T; Zhu D; Cui J; Liu X; Shen R; Zhu Y; Yang X
    Aging (Albany NY); 2019 Dec; 11(24):11814-11828. PubMed ID: 31881010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenomic pan-cancer landscape reveals immune escape mechanisms and immunoediting histories.
    Mizuno S; Yamaguchi R; Hasegawa T; Hayashi S; Fujita M; Zhang F; Koh Y; Lee SY; Yoon SS; Shimizu E; Komura M; Fujimoto A; Nagai M; Kato M; Liang H; Miyano S; Zhang Z; Nakagawa H; Imoto S
    Sci Rep; 2021 Aug; 11(1):15713. PubMed ID: 34344966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive transcriptome profiling in elderly cancer patients reveals aging-altered immune cells and immune checkpoints.
    Wu Y; Wei J; Chen X; Qin Y; Mao R; Song J; Fan Y
    Int J Cancer; 2019 Apr; 144(7):1657-1663. PubMed ID: 30230534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Analysis of the Oncogenic, Genomic Alteration, and Immunological Landscape of Cation-Chloride Cotransporters in Pan-Cancer.
    Wang J; Liu W; Xu W; Yang B; Cui M; Li Z; Zhang H; Jin C; Xue H; Zhang J
    Front Oncol; 2022; 12():819688. PubMed ID: 35372048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC02257, an Enhancer RNA of Prognostic Value in Colon Adenocarcinoma, Correlates With Multi-Omics Immunotherapy-Related Analysis in 33 Cancers.
    Xiao J; Liu Y; Yi J; Liu X
    Front Mol Biosci; 2021; 8():646786. PubMed ID: 33996902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory Network Analysis of Mutated Genes Based on Multi-Omics Data Reveals the Exclusive Features in Tumor Immune Microenvironment Between Left-Sided and Right-Sided Colon Cancer.
    Yi T; Zhang Y; Ng DM; Xi Y; Ye M; Cen L; Li J; Fan X; Li Y; Hu S; Rong H; Xie Y; Zhao G; Chen L; Chen C; Ni S; Mi J; Dai X; Liao Q
    Front Oncol; 2021; 11():685515. PubMed ID: 34211853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
    Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
    Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA-Pathway: a structural integration and visualization system of TCGA breast cancer data on KEGG pathways.
    Kim I; Choi S; Kim S
    BMC Bioinformatics; 2018 Feb; 19(Suppl 1):42. PubMed ID: 29504910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.